ClinicalTrials.Veeva

Menu

Mobile Phone-Based Smoking-Cessation Intervention for Smoking Parents

B

Beijing Normal University

Status

Not yet enrolling

Conditions

Smoking Cessation

Treatments

Behavioral: AI-powered chatbot support
Other: Health warning leaflet
Behavioral: 5A's/5R's advice

Study type

Interventional

Funder types

Other

Identifiers

NCT06570122
mCessation in smoking parents

Details and patient eligibility

About

This study aims to explore the feasibility and preliminary effectiveness of a mobile phone-based intervention tailored specifically for smoking parents.

Full description

Parental smoking is associated with numerous adverse outcomes, including exposure to secondhand smoke, heightened risk of respiratory illnesses in children, and an increased likelihood that children will adopt smoking behaviors themselves. Despite awareness of these risks, many parents find it challenging to quit smoking due to stress, lack of support, and time constraints.

This randomized controlled trial (RCT) investigates the effectiveness of a mobile phone-based intervention tailored specifically for smoking parents. The intervention group will receive AI-powered chatbot cessation support, while the control group will be provided with brief cessation advice. The study aims to determine whether the AI-driven intervention is more effective in helping parents quit smoking compared to traditional brief advice.

Enrollment

300 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. aged 18 and above, reside in Zhuhai for the next 6 months
  2. smoke at least 1 cigarette or use e-cigarettes daily
  3. have a smartphone and a WeChat account, able to use WeChat skillfully

Exclusion criteria

  1. Smokers who have communication barrier (either physically or cognitively)
  2. Smokers who are currently participating in other SC programmes or services

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

300 participants in 2 patient groups

AI chatbot support group
Experimental group
Description:
AI-powered chatbot support+ 5A's/5R's advice + health warning leaflet
Treatment:
Behavioral: 5A's/5R's advice
Other: Health warning leaflet
Behavioral: AI-powered chatbot support
Control group
Active Comparator group
Description:
5A's/5R's advice + health warning leaflet
Treatment:
Behavioral: 5A's/5R's advice
Other: Health warning leaflet

Trial contacts and locations

1

Loading...

Central trial contact

Xue Weng

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems